23. Prion disease Clinical trials / Disease details
Clinical trials : 4 / Drugs : 5 - (DrugBank : 2) / Drug target gene : 0 - Drug target pathway : 0
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2010-022233-28-IT (EUCTR) | 20/06/2011 | 05/03/2012 | Fatal familial insomnia: preventive treatment with doxycycline of at risk individuals - Doxycycline in FFI individuals | Subjects born between 1958 and 1969 belonging to the Treviso FFI family, tested previously for Prion D178N/129M mutation MedDRA version: 14.1;Level: SOC;Classification code 10029205;Term: Nervous system disorders;System Organ Class: 10029205 - Nervous system disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10] | Trade Name: BASSADO INN or Proposed INN: DOXYCYCLINE HYCLATE | IST. DI RICERCHE FARMACOLOG. M. NEGRI | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | Italy |